MacroGenics (MGNX) Reports Q1 Loss, Lags Revenue Estimates

MacroGenics (MGNX) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss of$ 0.61. This compares to loss of $0.84 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -6.56%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 0.23 per share when it actually produced a loss of $0.25, delivering a surprise of -8.70%.Over the last four quarters, the compan ...